Medi Caps MD, chairman, board of directors and AGM
NSE: MEDICAPQBSE: 523144Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹25.00.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹31 Cr3,735th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 May 2026
- 0.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- −1.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- −8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,595
Medi Caps board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorALOK K GARGRelated to the promoter
- Company Secretary and Compliance OfficerABHISHEK JAIN
5 directors3 independent2 executive
- ALOK K GARG · Chairperson and managing directorExecutive · joined Apr 2007 · 1 listed board
- SALONI GARGExecutive · joined Aug 2026 · 1 listed board
- ASHOK OMPRAKASH AGRAWALIndependent · joined Jul 2017 · reappointed Jul 2022 · 110 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- DHARMENDRA SOLANKIIndependent · joined Feb 2021 · reappointed Feb 2026 · 67 months as independent · 1 listed board · 1 as independent · 2 committee seats
- GAJENDRA SINGHIndependent · joined Aug 2023 · reappointed Aug 2023 · 37 months as independent · 1 listed board · 1 as independent · 2 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- RAMESH CHANDRA MITTAL, left 6 Aug 2026: Others
- KUSUM MITTAL, left 6 Aug 2026: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 6 Aug 20266 of 6 present3 independent · 76 days in between
- 21 May 20265 of 6 present3 independent
Audit Committee
Chair ASHOK OMPRAKASH AGRAWAL
DHARMENDRA SOLANKI, GAJENDRA SINGH
- 6 Aug 20263 of 3 present3 independent · 76 days in between
- 21 May 20263 of 3 present3 independent
Nomination and remuneration committee
Chair ASHOK OMPRAKASH AGRAWAL
DHARMENDRA SOLANKI, GAJENDRA SINGH
- 6 Aug 20263 of 3 present3 independent · 76 days in between
- 21 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair ASHOK OMPRAKASH AGRAWAL
DHARMENDRA SOLANKI, GAJENDRA SINGH
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Rawka & AssociatesPeer-review certificate valid to Apr 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Medi Caps AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Medi Caps dividend history
Annual general meeting, 22 Sep 2026
10,524 shareholders on the register on 15 Sep 2026; present: 8 promoters and 49 others; votes counted by Darshika Wankhede / Darshika Wankhede.The company's voting result (opens in a new tab)
(a) To consider and adopt the Audited Standalone Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended 31st March, 2026(b) To consider and adopt the Audited Consolidated Financial Statements of the Company together with the Report of the Auditors thereon for the financial year ended 31st March, 2026MoreLess
Ordinary98.77% for1.23% againstAgainst: promoters 0.00% · institutions 0.00% · other public 92.88%
Turnout: all 52.13% · promoters 100.00% · institutions 0.00% · other public 1.42%
- Re-appointment of Mr. Alok K Garg (DIN: 00274321), Chairman and Managing Director of the Company and Payment of Remuneration.SpecialPromoters have an interest in it98.77% for1.23% against
Against: promoters 0.00% · institutions 0.00% · other public 92.88%
Turnout: all 52.13% · promoters 100.00% · institutions 0.00% · other public 1.42%
- Confirmation of appointment of Mrs. Saloni Garg (DIN: 11865402) as a Director as well as Whole-Time Woman Director of the Company.SpecialPromoters have an interest in it98.77% for1.23% against
Against: promoters 0.00% · institutions 0.00% · other public 92.88%
Turnout: all 52.13% · promoters 100.00% · institutions 0.00% · other public 1.42%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeIncome Tax DepartmentSince 29 Jan 2016
The Company has filed an appeal before the Income Tax Appellate Tribunal (ITAT), Indore Bench, against the order dated 27 July 2026 passed by the Commissioner of Income Tax (Appeals) under Section 250 of the Income-tax Act, 1961, for AY 2014–15. The appeal was e-filed on 30 September 2026 and is pending adjudication.MoreLess
At the filing before: Appeal pending before the Commissioner of Income Tax (Appeals) for AY 2014–15 against the income-tax demand of Rs. 3,77,00,360.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.